{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T22:11:05Z","timestamp":1776723065730,"version":"3.51.2"},"reference-count":12,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.clml.2024.08.002","type":"journal-article","created":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T01:50:19Z","timestamp":1723254619000},"page":"869-872","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Systemic AL Amyloidosis in Patients Younger Than 40 Years of Age: Clinical Presentation and Outcomes"],"prefix":"10.1016","volume":"24","author":[{"given":"Karina","family":"Verma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Staron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luke","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Okan","family":"Cetin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gheorghe","family":"Doros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6307-2445","authenticated-orcid":false,"given":"Vaishali","family":"Sanchorawala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.clml.2024.08.002_bib0001","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41408-021-00529-w","article-title":"Marked progress in AL amyloidosis survival: a 40-year longitudinal natural history study","volume":"11","author":"Staron","year":"2021","journal-title":"Blood Cancer J"},{"issue":"10","key":"10.1016\/j.clml.2024.08.002_bib0002","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1182\/bloodadvances.2018016402","article-title":"Epidemiology of AL amyloidosis: a real-world study using US claims data","volume":"2","author":"Quock","year":"2018","journal-title":"Blood Adv"},{"issue":"118","key":"10.1016\/j.clml.2024.08.002_bib0003","first-page":"1","article-title":"Race\/ethnicity in systemic AL amyloidosis: perspectives on disease and outcome disparities","volume":"10","author":"Staron","year":"2020","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.clml.2024.08.002_bib0004","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41572-018-0034-3","article-title":"Systemic immunoglobulin light chain amyloidosis","volume":"4","author":"Merlini","year":"2018","journal-title":"Nat Rev Dis Primer"},{"issue":"3","key":"10.1016\/j.clml.2024.08.002_bib0005","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1182\/blood-2018-06-858951","article-title":"Development and validation of a survival staging system incorporating BNP in patients with light chain amyloidosis","volume":"133","author":"Lilleness","year":"2019","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.clml.2024.08.002_bib0006","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.clml.2021.01.021","article-title":"Clinical characteristics, treatment regimens, and survival in elderly patients with AL amyloidosis","volume":"21","author":"Acevedo","year":"2021","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"5","key":"10.1016\/j.clml.2024.08.002_bib0007","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41408-021-00486-4","article-title":"Comprehensive review of AL amyloidosis: some practical recommendations","volume":"11","author":"Al Hamed","year":"2021","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.clml.2024.08.002_bib0008","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/13506129.2017.1286584","article-title":"Outcome of very young (\u226440 years) patients with immunoglobulin light chain (AL) amyloidosis","volume":"24","author":"Abeykoon","year":"2017","journal-title":"Amyloid"},{"issue":"5","key":"10.1016\/j.clml.2024.08.002_bib0009","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/bjh.16096","article-title":"G. Ten-year survivors in AL amyloidosis: characteristics and treatment pattern","volume":"187","author":"Muchtar","year":"2019","journal-title":"Br J Haematol"},{"issue":"22","key":"10.1016\/j.clml.2024.08.002_bib0010","doi-asserted-by":"crossref","first-page":"5576","DOI":"10.1182\/blood.V128.22.5576.5576","article-title":"Outcome of very young (\u2264 40 years) patients with immunoglobulin light chain amyloidosis (AL): a case control study","volume":"128","author":"Abeykoon","year":"2016","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.clml.2024.08.002_bib0011","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/ajh.26641","article-title":"Predictors of hematologic response and survival with stem cell transplantation in AL amyloidosis: a 25-year longitudinal study","volume":"97","author":"Gustine","year":"2022","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2024.08.002_bib0012","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.3324\/haematol.12982","article-title":"Long-term risk of myelodysplasia in melphalan-treated patients with immunoglobulin light-chain amyloidosis","volume":"93","author":"Gertz","year":"2008","journal-title":"Haematologica"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265024002921?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265024002921?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T12:48:00Z","timestamp":1732538880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265024002921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":12,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S2152265024002921"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2024.08.002","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic AL Amyloidosis in Patients Younger Than 40 Years of Age: Clinical Presentation and Outcomes","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2024.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}